Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China
Medicine
[키워드] acute respiratory distress
analyzed
anticoagulation
anticoagulation treatment
antiviral drug
ARDS
branch
China
Clinical features
Comprehensive
coronavirus disease
correlation
COVID-19
COVID-19 patient
Critical
Critically ill
Critically ill patient
CRRT
cut-off value
Cytokines
effective
ESR
experience
Fluid management
glucocorticoid
IL-6
IL-8
Ill
Intervention
intubated patients
intubation
Invasive mechanical ventilation
laboratory data
management
moderate
Mortality
organ function
PaO
Patient
patients
procalcitonin
reached
reduce mortality
reducing mortality
renal replacement therapy
retrospective
Safe
Serum ferritin
severely and critically ill
shown
significantly higher
single-center study
Support
survival
syndrome
therapy
TNF-α
Tongji Hospital
Treatment
treatment for COVID-19
treatment strategy
Vaccine
Valley
ventilatory support
[DOI] 10.3389/fmed.2021.582764 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.582764 PMC 바로가기 [Article Type] Medicine